News

Roche announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Tecentriq (atezolizumab) as an adjuvant…
Read More...

Breckenridge Pharmaceutical, Inc. announces today that it has signed a new-product agreement with PTS Pharma, LLC. under which PTS will support a technology transfer to Towa…
Read More...

Suzhou Porton Advanced Solutions Ltd. ('Porton Advanced') and Guizhou Sinorda Biomedicine Co. Ltd ('Sinorda Biomedicine') announced a long-term strategic partnership in cell and gene…
Read More...

Thermo Fisher Scientific today celebrated the opening of its new single-use technology manufacturing site in Ogden, Utah. The state-of-the-art facility creates additional capacity to…
Read More...

Enzyvant, a commercial-stage biotechnology company with a focus on regenerative medicines for rare diseases, announced today plans to develop a Good Manufacturing Practice…
Read More...

Dragonfly Therapeutics, Inc. ("Dragonfly"), a biotechnology company developing novel immunotherapies that harness the innate immune system to treat disease, announced an expansion of…
Read More...

Codexis, Inc. and seqWell, Inc. announced the initiation of a strategic partnership and investment to accelerate the commercialization of seqWell’s genomics workflow solutions. Codexis,…
Read More...

Samsung Biologics announced that it has completed the purchase of Biogen’s stake in the Samsung Bioepis joint venture for USD $2.3 billion. With the completion of the first payment of…
Read More...

BioArctic AB (publ) has announced that the company's partner AbbVie has decided to terminate its collaboration with BioArctic regarding the portfolio of alpha-synuclein antibodies,…
Read More...

Vertex Pharmaceuticals Incorporated announced that Health Canada has granted Marketing Authorization for the expanded use of TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to…
Read More...

BenevolentAI, a leading clinical-stage artificial intelligence (AI) enabled drug discovery company, and Drugs for Neglected Disease initiative (DNDi), a not-for-profit research and…
Read More...

Kite, a Gilead Company announced the U.S. Food and Drug Administration (FDA) has approved commercial production at the company's new CAR T-cell therapy manufacturing facility in…
Read More...

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, and Matrix Clinical Trials, a Matrix Medical Network offering, are…
Read More...

Regeneron Pharmaceuticals, Inc. and Checkmate Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on proprietary technology to harness the power of the immune…
Read More...

Labcorp is collaborating with Xcell Biosciences, Inc. (Xcellbio) to advance critical work that helps clients effectively bring innovative cell and gene therapies to market. Through…
Read More...

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced a collaboration agreement with CtM Biotech (Shanghai) Co., Ltd (hereafter referred to as "CtM Bio") to jointly develop…
Read More...

Ankyra Therapeutics is pleased to announce that it has established a formal Cooperative Research and Development Agreement with the National Cancer Institute (NCI) to pursue basic,…
Read More...

Asahi Kasei Medical concluded an agreement on April 14, 2022 (JST) through a U.S. subsidiary to wholly acquire Bionova Scientific, LLC, a provider of contract process development…
Read More...

Takeda announced that it has received manufacturing and marketing approval from the Japan Ministry of Health, Labour and Welfare (MHLW) for Nuvaxovid® Intramuscular Injection…
Read More...

Ocugen, Inc. a biotechnology company focused on discovering, developing, and commercializing novel gene therapies, biologicals and vaccines, and Bharat Biotech (BBIL), a global leader…
Read More...